Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

drug development Press Releases

  + XML/RSS  



By Biotech Support Group
Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification

By Biotech Support Group
UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples

By Biotech Support Group
NuGel™ Glycoprotein Enrichment PBA product is ideal for mining glycoproteins and represents a new paradigm for biomarker discovery from glycoproteins.

By OneWorld Health/PATH
Dr. Ponni Subbiah will join OneWorld Health on August 1st, 2012 as its first global program leader.

By Biotech Support Group
Hemoglobin Depletion Plus Protein Enrichment From Dried Blood Spot (Blood Card) Technology

By Biotech Support Group
Signup to attend protein enrichment webinar series to explore proteomics and genomic sample preparation products and research featuring albumin depletion, urine protein enrichment, glycoproteins enrichment.

By CRC Press
Covers the regulatory requirements, scientific and practical issues, and statistical methodology for designing and evaluating bridging studies and multiregional clinical trials, with the goal of inspiring new research activities in the field.

By Biotech Support Group
Cleanascite™ for lipid removal and identification of biomarkers for environmental contamination from fish bile samples containing metalloproteinases

By Rosa & Co
Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012

By Rosa & Co
Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012.

By Alex Durand-Salmon
Banook, a leading clinical trial service provider, is pleased to announce the launch of Banook Central Imaging (www.banook-ci.com), a global service organization providing medical imaging services for clinical research area.

By Rosa & Co
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012.

By Cambridge Healthtech Institute
Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com

By Rosa & Co
Series of Seminars and Workshops to be held in 2012 across the US and in Europe

By Impuls Public Relations OG
Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.

By Cambridge Healthtech Institute
Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.

By Biopontis Alliance
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity

By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.

By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.

By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.

By ValueNotes
Recently published research shows a major shift in global pharmaceutical companies outsourcing core research and development (R&D) services such as drug development and clinical trials through strategic third-party collaborative partnerships.

By Cambridge Healthtech Institute
Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference

By ReportsnReports
Business Insight’s new report “New Emerging R&D Locations” is now available at ReportsnReports.com.

By Cambridge Healthtech Institute
Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

By ReportsnReports
Espicom Limited’s new report “Evolution in the Pain Therapy Drugs Market : Nociceptive and Neuropathic Drug Development” is now available at ReportsnReports.com.

By Camrbridge Healthtech Institute
Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!

By ReportsnReports
Kalorama Information’s new report “Outsourcing in Drug Development: The Contract Research (Clinical Trials) Market” is now available at ReportsnReports.com.

By SMi Group
Paediatric vaccine development: Some key clinical trials - their design, execution and ethics

By Rosa & Co
Integration Creates Seamless Data Management and Analysis Capability for ARA Customers

By Reportsnreports
Business Monitor International ‘s “Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)” is now available at ReportsnReports.com.

By Melbourn Scientific
New award at DDL22 recognises the contribution of young people to the pharmaceutical industry.

By Ashley Rowe
IQPC’s 7th Annual Compound Management & Integrity Summit brings together Pharmaceutical Professionals, Clinical Research Organizations and Industry Experts to address evolving industry concerns

By Compliance2go.com
Holders of the IND for new products i.e. the Sponsors. Also, Principal Investigators and sub investigators, Clinical Research Scientists Safety Nurses, Clinical Research Associates and Coordinators , Recruiting staff, QA / QC auditors and staff.

By SMi Group Ltd
SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.

By Ashley Rowe
IQPC’s Pharmacovigilance North America Summit brings together industry experts to address top industry concerns

By SMi Group
Biobanking - Collaborating for Global R&D and Investment 11th & 12th July 2011 Crowne Plaza - The City, London, UK

By Luminovas
Niiki Pharma will present Phase I clinical study data for its transferrin targeted ruthenium based anti-cancer compound, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL.

By Stephanie Flynn
Galera Therapeutics today announced Dr. Robert (Al) Beardsley as its new Chief Executive Officer.

By Dave Karasic, J.D.
The Boston-area formulation development CRO Integral BioSystems, LLC announces tradeshow presence at key pharmaceutical and biotech conferences, as part of its strategy to increase visibility.

By Cambridge Healthtech Institute
Cambridge Healthtech Institute announces two of the largest molecular imaging societies are sponsoring its In Vivo Molecular Imaging in Drug Discovery & Development event on June 8 – 9, in Philadelphia, as part of its World Pharma Congress.

By Rosa & Co
Alliance combines innovative exploratory study design, leading in silico drug development capabilities, and a global licensing network to increase the value of emerging company portfolios and address pipeline gaps for established drug manufacturers.

By SMi Group
Discuss with top the 50 pharma companies how to manage various types of pain through drugs and the development of new promising drugs from conception to clinical testing.

By SMi Group
Regulatory options for generics through different licensing possibilities and regulatory chalenges while working in MENA will be discussed by top 50 pharma companies

By Cambridge Healthtech Institute
75 Speaker presentations are available on CD from Cambridge Healthtech Institute’s past event, SCOPE: Summit for Clinical Ops Executives, which took place on February 7-9, 2011 in Miami, FL.

By BioAtla
BioAtla and Charles River have partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers from the earliest stages of discovery all the way through IND.

By SMi Group
With biobank collections increasing in value by medical researchers and drug developers worldwide, the biobank market is enjoying rapid growth in the number of national biobanks and efforts to build co-operative networks between them globally.

By SMi Group
Identify the key issues responsible for the low success rates in CNS drug discovery and development, to highlight strategies being developed to overcome these issues and to discuss how these may change the landscape for drug development.

By Menzies Consulting, Inc.
Company Leasing New Office Space, Increasing Workforce

By Q1 Productions
Ensuring a Cohesive Scientific and Business Approach to Early-Phase Clinical Research to Ensure the Development of Safe & Effective New Therapies

By Insight Pharma Reports
Nuclear Receptors: The Pipeline Outlook Report




Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share